Anti-VEGF Treatment for Retinopathy of Prematurity

Nowadays anti-VEGF treatment for ROP is increasingly gaining popularity on the way to replace laser as monotherapy. Besides its strikingly successful results debate depending upon positive and negative predictions in the literature with bothering medicolegal issues explains the need for such a review article aiming to clarify the current status and actual practice about anti-VEGF treatment for retinopathy of prematurity.